AXA S.A. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$29,433,000
-46.9%
150,406
-53.9%
0.11%
-2.8%
Q2 2020$55,460,000
+54.2%
326,382
+4.7%
0.11%
+21.1%
Q1 2020$35,962,000
-4.3%
311,682
-5.2%
0.09%
+18.4%
Q4 2019$37,582,000
+87.3%
328,918
+40.0%
0.08%
+90.0%
Q3 2019$20,068,000
-4.2%
234,978
-22.4%
0.04%
-2.4%
Q2 2019$20,954,000
+92.6%
302,762
+103.8%
0.04%
-4.7%
Q1 2019$10,878,000
+29.0%
148,530
-0.2%
0.04%
+16.2%
Q4 2018$8,435,000
-46.2%
148,864
-57.4%
0.04%
-45.6%
Q4 2015$15,667,000
+14.0%
349,082
-2.1%
0.07%
+21.4%
Q3 2015$13,744,000
-30.7%
356,420
-13.0%
0.06%
-29.1%
Q2 2015$19,821,000
+19.1%
409,525
-13.0%
0.08%
+14.5%
Q1 2015$16,640,000
+47.7%
470,714
+34.3%
0.07%
+53.3%
Q4 2014$11,264,000
+7.4%
350,575
+24.2%
0.04%0.0%
Q3 2014$10,492,000
-11.6%
282,190
-9.1%
0.04%
-8.2%
Q2 2014$11,873,000
-10.2%
310,397
+7.0%
0.05%
-15.5%
Q1 2014$13,221,000
+19.6%
290,181
+4.7%
0.06%
+16.0%
Q4 2013$11,056,000
-5.2%
277,151
+4.2%
0.05%
-12.3%
Q3 2013$11,657,000
+61.8%
265,950
+16.1%
0.06%
+50.0%
Q2 2013$7,204,000229,0020.04%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders